Behavioral
Mednow Clinics, INC
Mednow Clinics, INC was paid $9.56M by Medicaid between Jan 2018 and Dec 2024, across 106 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoMEDNOW CLINICS, INC
AURORA, CO 80014
AURORA, CO 80014
33aNPI1669888764assigned 07/09/2014
33bProvider typeAddiction (Substance Use Disorder) Counselor
28Total paid$9.56M
24GClaims318,321
24DCodes billed106
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Addiction (Substance Use Disorder) Counselor providers in Colorado
Rank by total paid#1 of 169
Median peer was paid$49K
This provider vs. median197×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,021 | $104K | |
| 2019 | 11,424 | $447K | |
| 2020 | 17,236 | $648K | |
| 2021 | 19,709 | $1.01M | |
| 2022 | 56,164 | $2.07M | |
| 2023 | 118,318 | $3.07M | |
| 2024incomplete | 93,449 | $2.21M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 36,153 | 29,961 | $2.81M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 24% | 21,641 | 14,284 | $2.30M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 9.5% | 6,118 | 5,586 | $911K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.1% | 10,354 | 9,107 | $580K |
| J2315 | Injection, naltrexone, depot form, 1 mg | 5.7% | 429 | 390 | $540K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.6% | 3,579 | 3,340 | $438K |
| 96127 | 3.9% | 33,718 | 29,192 | $369K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.6% | 9,867 | 8,936 | $343K |
| 80305 | 1.9% | 16,641 | 14,650 | $186K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.9% | 2,187 | 1,966 | $180K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 1.5% | 85 | 76 | $141K |
| 99205 | Prolong outpt/office vis | 1.4% | 982 | 915 | $137K |
94 more codes
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 1,276 | $120K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 975 | $89K |
| 99385 | <1% | 519 | $56K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,400 | $39K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,756 | $31K |
| 99401 | <1% | 1,087 | $29K | |
| H0001 | Alcohol and/or drug assessment | <1% | 267 | $25K |
| 99417 | Prolong home eval add 15m | <1% | 340 | $20K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,302 | $19K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 323 | $15K |
| 90715 | <1% | 295 | $13K | |
| 90686 | <1% | 728 | $11K | |
| 99402 | <1% | 228 | $11K | |
| 93000 | <1% | 633 | $10K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,068 | $10K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 943 | $10K |
| 97803 | <1% | 140 | $9K | |
| 99000 | <1% | 4,957 | $8K | |
| 87631 | <1% | 71 | $8K | |
| 99386 | <1% | 62 | $7K | |
| 20553 | <1% | 214 | $7K | |
| 90674 | <1% | 364 | $7K | |
| 87428 | <1% | 98 | $7K | |
| 97802 | <1% | 130 | $6K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 196 | $5K |
| 81002 | <1% | 3,215 | $4K | |
| 81025 | <1% | 521 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 464 | $4K |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) | <1% | 393 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 225 | $2K |
| 99173 | <1% | 257 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 132 | $2K |
| 0013A | <1% | 48 | $2K | |
| 62323 | <1% | 28 | $2K | |
| 0003A | <1% | 42 | $1K | |
| 0134A | <1% | 36 | $1K | |
| 27096 | <1% | 14 | $1K | |
| 99408 | <1% | 66 | $1K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 41 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 26 | $1K |
| 90682 | <1% | 29 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 159 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 17 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 51 | $946.41 |
| 90837 | Psychotherapy session, about an hour | <1% | 123 | $826.65 |
| 81007 | <1% | 44 | $781.31 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 25 | $744.18 |
| 99490 | Ccm add 20min | <1% | 43 | $570.54 |
| 0124A | <1% | 15 | $550.00 | |
| 80061 | Lipid panel | <1% | 39 | $546.03 |
| 0011A | <1% | 13 | $520.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 19 | $511.22 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 187 | $510.00 |
| 20610 | <1% | 15 | $448.89 | |
| 90662 | <1% | 15 | $232.60 | |
| 82947 | <1% | 40 | $167.27 | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 141 | $141.08 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 33 | $136.24 |
| 99397 | <1% | 12 | $82.64 | |
| 96160 | <1% | 153 | $80.99 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 62 | $74.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 76 | $60.29 |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 14 | $37.30 |
| G0008 | Administration of influenza virus vaccine | <1% | 38 | $22.24 |
| 91300 | <1% | 109 | $16.00 | |
| 1111F | <1% | 1,169 | $7.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 43 | $1.36 |
| 3074F | 0% | 22,593 | $0.00 | |
| 3080F | 0% | 2,820 | $0.00 | |
| 1036F | 0% | 12,950 | $0.00 | |
| 3075F | 0% | 4,776 | $0.00 | |
| 3008F | 0% | 26,794 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 52 | $0.00 |
| 3079F | 0% | 13,088 | $0.00 | |
| 1034F | 0% | 3,662 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 47 | $0.00 |
| 1123F | 0% | 150 | $0.00 | |
| 1126F | 0% | 317 | $0.00 | |
| 1035F | 0% | 667 | $0.00 | |
| 1125F | 0% | 456 | $0.00 | |
| 3044F | 0% | 90 | $0.00 | |
| 91301 | 0% | 88 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 18 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 41 | $0.00 |
| 3725F | 0% | 11,793 | $0.00 | |
| 1159F | 0% | 20,954 | $0.00 | |
| 3078F | 0% | 14,045 | $0.00 | |
| 3077F | 0% | 2,754 | $0.00 | |
| 1160F | 0% | 592 | $0.00 | |
| 3288F | 0% | 138 | $0.00 | |
| 91313 | 0% | 36 | $0.00 | |
| 3046F | 0% | 14 | $0.00 | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 53 | $0.00 |
| 91312 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, NATHANIEL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| A Blessing Personal Home Care | Lafayette, LA | $6.38M |
| A Blessing Personal Home Care | Lafayette, LA | $4.05M |
| A Blessing Personal Home Care | Alexandria, LA | $3.33M |
| Mednow Clinics, INC | Denver, CO | $53K |
| Mednow Clinics, INC. | Lakewood, CO | $732.17 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.